NCT06445062: Revolution Medicines trial combining RMC-6236 with either FOLFIRINOX or Gemcitabine/nab-paclitaxel in treatment naive #PancreaticCancer. This study is now open at 17 locations nationwide. Also includes sub-cohorts for #ColorectalCancer and 2nd line pancreatic cancer.

If you conduct or use single cell RNA-seq data from both humans and mice in your lab, this preprint releases a very useful tool called scVital. Developed by Doron Betel (with a cameo by Tuomas Tammela) scVital enables cross species interrogation and integration of cell states, and is

Merry Xmas everyone!! Feliz Navidad a todxs!!! Eguberri on!!!

NIH appears to have canceled/postponed all of its study sections: these are the independent review panels that approve federal grants for health research. Such grants fund the work/salaries of more than 300k people at more than 2,500 institutions

USA- 9/11: victims and the heroes who helped are honored, alongside a unified message of equality and the fight against terrorism. Spain-3/11: I don’t see a single headline about it in the country’s main newspapers...Perhaps there’s no interest in coming together for that. SHAME!

Thanks AACR for inviting me to talk about RNA-based precision medicine and vertebrate models at the #AACRprecmed25 with incredible panelists. Such a great experience!! AACR AACR Foundation

New report shows that NIH grants fueled $95 billion in economic activity and >400k jobs in 2024. That's not to mention THE LIVES that biomedical research has SAVED. I think is not a bad investment… isn’t it??? forbes.com/sites/michaelt…

Truly honored and humbled to receive the Scholar-In-Training Award from AACR & Sanofi US. I will be presenting a novel KRAS-related and #hypoxia metabolism modulator in #PancreaticCancer. Looking forward to meeting people and expand science #AACR25 KenOliveLab Columbia Medicine

On my way to #AACR25 in Chicago. Looking forward to seeing the latest news on cancer research & meet people. Thanks Sanofi -AACR for the opportunity to present my poster (Monday 9am-12pm) about hypoxia and regulatory network analysis in pancreatic cancer. DM if want to connect

#AACR25 starts now. The event of the year for cancer researchers. A place to meet new colleagues, hang out with old friends, discuss science and see the latests news in the field with an incredible scientific program. Let’s work together!! AACR AACR Foundation

🚨Tomorrow morning I'll be presenting my poster linking hypoxia metabolism and KRAS in pancreatic cancer using regulatory network analysis. (Section 13, Board 6). Thanks Sanofi and AACR for the Scholar in Training Award. Stop by and let's talk and connect!! #AACR25

Why the AACR annual meeting is so important? Because it brings people from the whole world to present science and latests advances, as well as build collaborations with a variety of sessions. The personal and professional value is unique. #AACR25

Honored to be named one of the 2025 #40Under40InCancer awardees! Grateful to my mentors, and to all the colleagues who’ve guided my path in systems oncology & pancreatic cancer. Proud to be part of this inspiring group! #Oncology #YoungLeaders Herbert Irving Comprehensive Cancer Center Columbia Medicine #Avbcc

🔬 Regulatory network analysis in human pancreatic cancer samples identified BMAL2 as a KRAS-linked TF that enables tumors to adapt to hypoxia, providing new insight into the metabolic plasticity & hypoxia adaptations driven by oncogenic KRAS biorxiv.org/content/10.110…

📻 Carlos Alsina lanza una plegaria por esos ministros y dirigentes que ayer perdieron "Una mano. O las dos." 💬 "El líder pide perdón. Él, que exigió a los demás que se disculparan con los injustamente difamados, ha tenido que disculparse por no haber querido ver lo que había.

My lab was totally destroyed tonight by an Iranian missile. Nobody was hurt. Flies, plasmids, cells, equipment - all gone. Heart breaking. If during the course of the past 16 years, you have received something from my lab - please keep them safe.

📻 📺 Carlos Alsina y Susana Griso reflexionan en Espejo Público sobre la comparecencia de ayer del Presidente y sobre los actuales apoyos del Gobierno. 💬 Alsina: "Sé que Junts per Cataluña hace 4 días como quien dice le exigía Sánchez que se debatiera en el Congreso una

Back from my first #GRC on #PancreaticDiseases—what an amazing experience!Grateful for the chance to present our work on a KRAS–hypoxia master regulator in PDAC and to serve as a GRS discussion leader on cellular plasticity.Thanks to the organizers and #CarlStorm for the support!